Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2731]

Approval of targeted therapies first line for prostate cancer ‘will ease Covid-19 pressures’

Approval of targeted therapies first line for prostate cancer ‘will ease Covid-19 pressures’

Innovative approach offers option for treating upper tract urothelial cancer

Innovative approach offers option for treating upper tract urothelial cancer

Positive results from pivotal phase 3 trial evaluating nivolumab plus ipilimumab vs chemotherapy in previously untreated malignant pleural mesothelioma

Positive results from pivotal phase 3 trial evaluating nivolumab plus ipilimumab vs chemotherapy in previously...

AACR 2020: Study shows immunotherapy prior to surgery may help destroy high-risk breast cancer

AACR 2020: Study shows immunotherapy prior to surgery may help destroy high-risk breast cancer

Blood test offers early warning of chemotherapy-related heart problems

Blood test offers early warning of chemotherapy-related heart problems

AACR 2020: Study finds no overall survival benefit, but improved quality of life with talazoparib in advanced BRCA-mutated breast cancer

AACR 2020: Study finds no overall survival benefit, but improved quality of life with talazoparib in advanced BRCA...

Pancreatic cancer cells hijack basic cell mechanism to evade immunotherapy

Pancreatic cancer cells hijack basic cell mechanism to evade immunotherapy

A cellular mechanism protecting against cancer

A cellular mechanism protecting against cancer

New targeted agent produces considerable responses in patients with uterine cancer

New targeted agent produces considerable responses in patients with uterine cancer

Combinations of paclitaxel and withaferin A against human non-small cell lung cancer

Combinations of paclitaxel and withaferin A against human non-small cell lung cancer

More from ecancer